These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15530630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transient neonatal liver disease after maternal antenatal intravenous Ig infusions in gestational alloimmune liver disease associated with neonatal haemochromatosis.
    Baruteau J, Heissat S, Broué P, Collardeau-Frachon S, Bouvier R, Fabre M, Debiec H, Ronco P, Uzan M, Narcy P, Cordier MP, Lachaux A, Lamireau T, Elleau C, Filet JP, Mitanchez D, Dupuy MP, Salaün JF, Odent S, Davison J, Debray D, Guigonis V.
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):629-35. PubMed ID: 25079484
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis.
    Venkat-Raman N, Venkata-Krishnan RV, Howarth ES.
    Prenat Diagn; 2006 Dec; 26(13):1256-9. PubMed ID: 17099927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation.
    Whitington PF, Kelly S, Taylor SA, Nóbrega S, Schreiber RA, Sokal EM, Hibbard JU.
    Fetal Diagn Ther; 2018 Dec; 43(3):218-225. PubMed ID: 28787718
    [Abstract] [Full Text] [Related]

  • 9. Successful pregnancy outcome with the use of antenatal high-dose intravenous immunoglobulin following previous neonatal death associated with neonatal haemochromatosis.
    Nicholl MC.
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):403-5. PubMed ID: 20716273
    [No Abstract] [Full Text] [Related]

  • 10. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
    Thung SF, Grobman WA.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of neonatal hemochromatosis as gestational alloimmune liver disease with intravenous immunoglobulin.
    Jimenez-Rivera C, Gupta A, Feberova J, de Nanassy JA, Boland MP.
    J Neonatal Perinatal Med; 2014 Sep; 7(4):301-4. PubMed ID: 25468619
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prophylactic prenatal therapy with intravenous immunoglobulins for patients at risk for neonatal haemochromatosis].
    Faas D, Axt-Fliedner R, Zimmer KP, Heckmann M.
    Z Geburtshilfe Neonatol; 2011 Dec; 215(6):246-9. PubMed ID: 22274935
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. French retrospective multicentric study of neonatal hemochromatosis: importance of autopsy and autoimmune maternal manifestations.
    Collardeau-Frachon S, Heissat S, Bouvier R, Fabre M, Baruteau J, Broue P, Cordier MP, Debray D, Debiec H, Ronco P, Guigonis V.
    Pediatr Dev Pathol; 2012 Dec; 15(6):450-70. PubMed ID: 22901025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.